421 results on '"Leipsic, Jonathon"'
Search Results
2. Long-term prognostic implications of hemodynamic and plaque assessment using coronary CT angiography
- Author
-
Yang, Seokhun, Lesina, Krista, Doh, Joon-Hyung, Jegere, Sanda, Erglis, Andrejs, Leipsic, Jonathon A., Chun, Eun Ju, Choi, Gilwoo, Schaap, Michiel, Zarins, Christopher, Taylor, Charles A., Fearon, William F., Narula, Jagat, and Koo, Bon-Kwon
- Published
- 2023
- Full Text
- View/download PDF
3. Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Patients With and Without Diabetes: Long-Term Outcomes From the CONFIRM Registry
- Author
-
Lee, Juhwan, Shaikh, Kashif, Nakanishi, Rine, Gransar, Heidi, Achenbach, Stephan, Al-Mallah, Mouaz H., Andreini, Daniele, Bax, Jeroen J., Berman, Daniel S., Cademartiri, Filippo, Callister, Tracy Q., Chang, Hyuk-Jae, Chinnaiyan, Kavitha, Chow, Benjamin J.W., Cury, Ricardo C., DeLago, Augustin, Feuchtner, Gudrun, Hadamitzky, Martin, Hausleiter, Joerg, Kaufmann, Philipp A., Kim, Yong-Jin, Leipsic, Jonathon A., Maffei, Erica, Marques, Hugo, de Araújo Gonçalves, Pedro, Pontone, Gianluca, Rubinshtein, Ronen, Villines, Todd C., Lu, Yao, Peña, Jessica M., Lin, Fay Y., Min, James K., Shaw, Leslee J., and Budoff, Matthew J.
- Published
- 2023
- Full Text
- View/download PDF
4. Cardiac computed tomography post-transcatheter aortic valve replacement.
- Author
-
He, Albert, Wilkins, Ben, Lan, Nick S.R., Othman, Farrah, Sehly, Amro, Bhat, Vikas, Jaltotage, Biyanka, Dwivedi, Girish, Leipsic, Jonathon, and Ihdayhid, Abdul Rahman
- Abstract
Transcatheter aortic valve replacement (TAVR) is performed to treat aortic stenosis and is increasingly being utilised in the low-to-intermediate-risk population. Currently, attention has shifted towards long-term outcomes, complications and lifelong maintenance of the bioprosthesis. Some patients with TAVR in-situ may develop significant coronary artery disease over time requiring invasive coronary angiography, which may be problematic with the TAVR bioprosthesis in close proximity to the coronary ostia. In addition, younger patients may require a second transcatheter heart valve (THV) to 'replace' their in-situ THV because of gradual structural valve degeneration. Implantation of a second THV carries a risk of coronary obstruction, thereby requiring comprehensive pre-procedural planning. Unlike in the pre-TAVR period, cardiac CT angiography in the post-TAVR period is not well established. However, post-TAVR cardiac CT is being increasingly utilised to evaluate mechanisms for structural valve degeneration and complications, including leaflet thrombosis. Post-TAVR CT is also expected to have a significant role in risk-stratifying and planning future invasive procedures including coronary angiography and valve-in-valve interventions. Overall, there is emerging evidence for post-TAVR CT to be eventually incorporated into long-term TAVR monitoring and lifelong planning. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Patient-Prosthesis Mismatch After Surgical Aortic Valve Replacement: Analysis of the PARTNER Trials.
- Author
-
Thourani, Vinod H., Abbas, Amr E., Ternacle, Julien, Hahn, Rebecca T., Makkar, Raj, Kodali, Susheel K., George, Isaac, Kapadia, Samir, Svensson, Lars G., Szeto, Wilson Y., Herrmann, Howard C., Ailawadi, Gorav, Leipsic, Jonathon, Blanke, Philipp, Webb, John, Jaber, Wael A., Russo, Mark, Malaisrie, S. Chris, Yadav, Pradeep, and Clavel, Marie-Annick
- Abstract
Our objective was to compare the impact of patient-prosthesis mismatch (PPM) for 2 years after surgical aortic valve replacement within the prospective, randomized Placement of Aortic Transcatheter Valves (PARTNER) trials. Surgical aortic valve replacement patients from the PARTNER 1, 2, and 3 trials were included. PPM was classified as moderate (indexed effective orifice area ≤0.85 cm
2 /m2 ) or severe (indexed effective orifice area ≤0.65 cm2 /m2 ). The primary endpoint was the composite of all-cause death and heart failure rehospitalization at 2 years. By the predicted PPM method (PPM P), 59.1% had no PPM, 38.8% moderate PPM, and 2.1% severe PPM; whereas by the measured PPM method (PPM M), 42.4% had no PPM, 36.0% moderate, and 21.6% severe. Patients with no PPM P (23.6%) had a lower rate of the primary endpoint compared with patients with moderate (28.2%, P =.03) or severe PPM P (38.8%, P =.02). Using the PPM M method, there was no difference between the no (17.7%) and moderate PPM M groups (21.1%) in the primary outcome (P =.16). However, those with no PPM M or moderate PPM M were improved compared with severe PPM M (27.4%, P <.001 and P =.02, respectively). Severe PPM analyzed by PPM P was only 2.1% for surgical aortic valve replacement patients. The PPM M method overestimated the incidence of severe PPM relative to PPM P , but was also associated with worse outcome. There was higher all-cause mortality in patients with severe PPM, thus surgical techniques to minimize PPM remain critical. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
6. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors
- Author
-
Won, Ki-Bum, Heo, Ran, Park, Hyung-Bok, Lee, Byoung Kwon, Lin, Fay Y., Hadamitzky, Martin, Kim, Yong-Jin, Sung, Ji Min, Conte, Edoardo, Andreini, Daniele, Pontone, Gianluca, Budoff, Matthew J., Gottlieb, Ilan, Chun, Eun Ju, Cademartiri, Filippo, Maffei, Erica, Marques, Hugo, de Araújo Gonçalves, Pedro, Leipsic, Jonathon A., Lee, Sang-Eun, Shin, Sanghoon, Choi, Jung Hyun, Virmani, Renu, Samady, Habib, Chinnaiyan, Kavitha, Berman, Daniel S., Narula, Jagat, Shaw, Leslee J., Bax, Jeroen J., Min, James K., and Chang, Hyuk-Jae
- Published
- 2021
- Full Text
- View/download PDF
7. Prognostic significance of subtle coronary calcification in patients with zero coronary artery calcium score: From the CONFIRM registry
- Author
-
Han, Donghee, Klein, Eyal, Friedman, John, Gransar, Heidi, Achenbach, Stephan, Al-Mallah, Mouaz H., Budoff, Matthew J., Cademartiri, Filippo, Maffei, Erica, Callister, Tracy Q., Chinnaiyan, Kavitha, Chow, Benjamin J.W., DeLago, Augustin, Hadamitzky, Martin, Hausleiter, Joerg, Kaufmann, Philipp A., Villines, Todd C., Kim, Yong-Jin, Leipsic, Jonathon, Feuchtner, Gudrun, Cury, Ricardo C., Pontone, Gianluca, Andreini, Daniele, Marques, Hugo, Rubinshtein, Ronen, Chang, Hyuk-Jae, Lin, Fay Y., Shaw, Leslee J., Min, James K., and Berman, Daniel S.
- Published
- 2020
- Full Text
- View/download PDF
8. Colchicine and plaque: A focus on atherosclerosis imaging.
- Author
-
Aldana-Bitar, Jairo, Golub, Ilana S., Moore, Jeff, Krishnan, Srikanth, Verghese, Dhiran, Manubolu, Venkat S., Benzing, Travis, Ichikawa, Keshi, Hamal, Sajad, Kianoush, Sina, Anderson, Lauren R., Ramirez, Noah R., Leipsic, Jonathon A., Karlsberg, Ronald P., and Budoff, Matthew J.
- Abstract
Colchicine is an anti-inflammatory medication, classically used to treat a wide spectrum of autoimmune diseases. More recently, colchicine has proven itself a key pharmacotherapy in cardiovascular disease (CVD) management, atherosclerotic plaque modification, and coronary artery disease (CAD) treatment. Colchicine acts on many anti-inflammatory pathways, which translates to cardiovascular event reduction, plaque transformation, and plaque reduction. With the FDA's 2023 approval of colchicine for reducing cardiovascular events, a novel clinical pathway opens. This advancement paves the route for CVD management that synergistically merges lipid lowering approaches with inflammation inhibition modalities. This pioneering moment spurs the need for this manuscript's comprehensive review. Hence, this paper synthesizes and surveys colchicine's new role as an atherosclerotic plaque modifier, to provide a framework for physicians in the clinical setting. We aim to improve understanding (and thereby application) of colchicine alongside existing mechanisms for CVD event reduction. This paper examines colchicine's anti-inflammatory mechanism, and reviews large cohort studies that evidence colchicine's blossoming role within CAD management. This paper also outlines imaging modalities for atherosclerotic analysis, reviews colchicine's mechanistic effect upon plaque transformation itself, and synthesizes trials which assess colchicine's nuanced effect upon atherosclerotic transformation. • Colchicine is a well-studied anti-inflammatory medication, more recently, its pivotal role in cardiovascular disease management and atherosclerotic plaque modification has been established. • Colchicine acts on many anti-inflammatory pathways, which translates to cardiovascular event reduction, plaque transformation, and plaque reduction. • Plaque analysis of colchicine effects may be performed invasively or noninvasively, each with its own advantages and limitations. • Colchicine's role in plaque transformation and positive clinical outcomes paves the way for its incorporation into clinical guidelines and practice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Comparative Prognostic Utility of Coronary CT and Invasive Angiography: Insights From the ISCHEMIA Trial.
- Author
-
Leipsic, Jonathon, Ben Zekry, Sagit, Tzimas, Georgios, Broderick, Samuel, Mancini, G.B. John, Hague, Cameron J., Budoff, Matt J., Rockhold, Frank W., Chaitman, Bernard R., Kirby, Ruth, Stone, Gregg W., Ali, Ziad A., Min, James K., Hochman, Judith S., Maron, David J., and Reynolds, Harmony R.
- Published
- 2024
- Full Text
- View/download PDF
10. Prediction of the development of new coronary atherosclerotic plaques with radiomics.
- Author
-
Lee, Sang-Eun, Hong, Youngtaek, Hong, Jongsoo, Jung, Juyeong, Sung, Ji Min, Andreini, Daniele, Al-Mallah, Mouaz H., Budoff, Matthew J., Cademartiri, Filippo, Chinnaiyan, Kavitha, Choi, Jung Hyun, Chun, Eun Ju, Conte, Edoardo, Gottlieb, Ilan, Hadamitzky, Martin, Kim, Yong Jin, Lee, Byoung Kwon, Leipsic, Jonathon A., Maffei, Erica, and Marques, Hugo
- Abstract
Radiomics is expected to identify imaging features beyond the human eye. We investigated whether radiomics can identify coronary segments that will develop new atherosclerotic plaques on coronary computed tomography angiography (CCTA). From a prospective multinational registry of patients with serial CCTA studies at ≥ 2-year intervals, segments without identifiable coronary plaque at baseline were selected and radiomic features were extracted. Cox models using clinical risk factors (Model 1), radiomic features (Model 2) and both clinical risk factors and radiomic features (Model 3) were constructed to predict the development of a coronary plaque, defined as total PV ≥ 1 mm
3 , at follow-up CCTA in each segment. In total, 9583 normal coronary segments were identified from 1162 patients (60.3 ± 9.2 years, 55.7% male) and divided 8:2 into training and test sets. At follow-up CCTA, 9.8% of the segments developed new coronary plaque. The predictive power of Models 1 and 2 was not different in both the training and test sets (C-index [95% confidence interval (CI)] of Model 1 vs. Model 2 : 0.701 [0.690–0.712] vs. 0.699 [0.0.688–0.710] and 0.696 [0.671–0.725] vs. 0.0.691 [0.667–0.715], respectively, all p > 0.05). The addition of radiomic features to clinical risk factors improved the predictive power of the Cox model in both the training and test sets (C-index [95% CI] of Model 3 : 0.772 [0.762–0.781] and 0.767 [0.751–0.787], respectively, all p < 00.0001 compared to Models 1 and 2). Radiomic features can improve the identification of segments that would develop new coronary atherosclerotic plaque. ClinicalTrials.gov NCT0280341. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
11. Long-term prognostic implications of CT angiography-derived fractional flow reserve: Results from the DISCOVER-FLOW study.
- Author
-
Yang, Seokhun, Chung, Jaewook, Lesina, Krista, Doh, Joon-Hyung, Jegere, Sanda, Erglis, Andrejs, Leipsic, Jonathon A., Fearon, William F., Narula, Jagat, and Koo, Bon-Kwon
- Abstract
The long-term prognostic implications of CT angiography-derived fractional flow reserve (FFR CT) remains unclear. We aimed to explore the long-term outcomes of FFR CT in the first-in-human study of it. A total of 156 vessels from 102 patients with stable coronary artery disease, who underwent coronary CT angiography (CCTA) and invasive FFR measurement, were followed. The primary endpoint was target vessel failure (TVF), including cardiovascular death, target vessel myocardial infarction, and target vessel revascularization. Outcome analysis with FFR CT was performed on a per-vessel basis using a marginal Cox proportional hazard model. During median 9.9 years of follow-up, TVF occurred in 20 (12.8%) vessels. FFR CT ≤0.80 discriminated TVF (hazard ratio [HR] 2.61, 95% confidence interval [CI] 1.06, 6.45). Among 94 vessels with deferral of percutaneous coronary intervention (PCI), TVF risk was inversely correlated with FFR CT (HR 0.62 per 0.1 increase, 95% CI 0.44, 0.86), with the cumulative incidence of TVF being 2.6%, 15.2%, and 28.6% for vessels with FFR CT >0.90, 0.81–0.90, and ≤0.80, respectively (p-for-trend 0.005). Predictive value for clinical outcomes of FFR CT was similar to that of invasive FFR (c-index 0.79 vs 0.71, P = 0.28). The estimated TVF risk was higher in the deferral of PCI group than the PCI group for vessels with FFR CT ≤0.81. FFR CT showed improved long-term risk stratification and displayed a risk continuum similar to invasive FFR. NCT01189331. Table of Contents Summary. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Coronary computed tomography angiography derived fractional flow reserve and risk of recurrent angina: A 3-year follow-up study.
- Author
-
Madsen, Kristian Tækker, Nørgaard, Bjarne Linde, Øvrehus, Kristian Altern, Jensen, Jesper Møller, Parner, Erik, Grove, Erik Lerkevang, Mortensen, Martin B., Fairbairn, Timothy A., Nieman, Koen, Patel, Manesh R., Rogers, Campbell, Mullen, Sarah, Mickley, Hans, Thomsen, Kristian Korsgaard, Bøtker, Hans Erik, Leipsic, Jonathon, and Sand, Niels Peter Rønnow
- Abstract
The association between coronary computed tomography angiography (CTA) derived fractional flow reserve (FFR CT) and risk of recurrent angina in patients with new onset stable angina pectoris (SAP) and stenosis by CTA is uncertain. Multicenter 3-year follow-up study of patients presenting with symptoms suggestive of new onset SAP who underwent first-line CTA evaluation and subsequent standard-of-care treatment. All patients had at least one ≥30 % coronary stenosis. A per-patient lowest FFR CT -value ≤0.80 represented an abnormal test result. Patients with FFR CT ≤0.80 who underwent revascularization were categorized according to completeness of revascularization: 1) Completely revascularized (CR-FFR CT), all vessels with FFR CT ≤0.80 revascularized; or 2) incompletely revascularized (IR-FFR CT) ≥1 vessels with FFR CT ≤0.80 non-revascularized. Recurrent angina was evaluated using the Seattle Angina Questionnaire. Amongst 769 patients (619 [80 %] stenosis ≥50 %, 510 [66 %] FFR CT ≤0.80), 174 (23 %) reported recurrent angina at follow-up. An FFR CT ≤0.80 vs > 0.80 associated to increased risk of recurrent angina, relative risk (RR): 1.82; 95 % CI: 1.31–2.52, p < 0.001. Risk of recurrent angina in CR-FFR CT (n = 135) was similar to patients with FFR CT >0.80, 13 % vs 15 %, RR: 0.93; 95 % CI: 0.62–1.40, p = 0.72, while IR-FFR CT (n = 90) and non-revascularized patients with FFR CT ≤0.80 (n = 285) had increased risk, 37 % vs 15 % RR: 2.50; 95 % CI: 1.68–3.73, p < 0.001 and 30 % vs 15 %, RR: 2.03; 95 % CI: 1.44–2.87, p < 0.001, respectively. Use of antianginal medication was similar across study groups. In patients with SAP and coronary stenosis by CTA undergoing standard-of-care guided treatment, FFR CT provides information regarding risk of recurrent angina. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Comprehensive Myocardial Assessment by Computed Tomography: Impact on Short-Term Outcomes After Transcatheter Aortic Valve Replacement.
- Author
-
Koike, Hideki, Fukui, Miho, Treibel, Thomas, Stanberry, Larissa I., Cheng, Victor Y., Enriquez-Sarano, Maurice, Schmidt, Stephanie, Schelbert, Erik B., Wang, Cheng, Okada, Atsushi, Phichaphop, Asa, Sorajja, Paul, Bapat, Vinayak N., Leipsic, Jonathon, Lesser, John R., and Cavalcante, João L.
- Abstract
Quantification of myocardial changes in severe aortic stenosis (AS) is prognostically important. The potential for comprehensive myocardial assessment pre–transcatheter aortic valve replacement (TAVR) by computed tomography angiography (CTA) is unknown. This study sought to evaluate whether quantification of left ventricular (LV) extracellular volume—a marker of myocardial fibrosis—and global longitudinal strain—a marker of myocardial deformation—at baseline CTA associate with post-TAVR outcomes. Consecutive patients with symptomatic severe AS between January 2021 and June 2022 who underwent pre-TAVR CTA were included. Computed tomography extracellular volume (CT-ECV) was derived from septum tracing after generating the 3-dimensional CT-ECV map. Computed tomography global longitudinal strain (CT-GLS) used semi-automated feature tracking analysis. The clinical endpoint was the composite outcome of all-cause mortality and heart failure hospitalization. Among the 300 patients (80.0 ± 9.4 years of age, 45% female, median Society of Thoracic Surgeons Predicted Risk of Mortality score 2.80%), the left ventricular ejection fraction (LVEF) was 58% ± 12%, the median CT-ECV was 28.5% (IQR: 26.2%-32.1%), and the median CT-GLS was −20.1% (IQR: −23.8% to −16.3%). Over a median follow-up of 16 months (IQR: 12-22 months), 38 deaths and 70 composite outcomes occurred. Multivariable Cox proportional hazards model, accounting for clinical and echocardiographic variables, demonstrated that CT-ECV (HR: 1.09 [95% CI: 1.02-1.16]; P = 0.008) and CT-GLS (HR: 1.07 [95% CI: 1.01-1.13]; P = 0.017) associated with the composite outcome. In combination, elevated CT-ECV and CT-GLS (above median for each) showed a stronger association with the outcome (HR: 7.14 [95% CI: 2.63-19.36]; P < 0.001). Comprehensive myocardial quantification of CT-ECV and CT-GLS associated with post-TAVR outcomes in a contemporary low-risk cohort with mostly preserved LVEF. Whether these imaging biomarkers can be potentially used for the decision making including timing of AS intervention and post-TAVR follow-up will require integration into future clinical trials. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Age- and Sex-Specific Nomographic CT Quantitative Plaque Data From a Large International Cohort.
- Author
-
Tzimas, Georgios, Gulsin, Gaurav S., Everett, Russell J., Akodad, Mariama, Meier, David, Sewnarain, Kavishka, Ally, Zain, Alnamasy, Rawan, Ng, Nicholas, Mullen, Sarah, Rotzinger, David, Sathananthan, Janarthanan, Sellers, Stephanie L., Blanke, Philipp, and Leipsic, Jonathon A.
- Abstract
With growing adoption of coronary computed tomographic angiography (CTA), there is increasing evidence for and interest in the prognostic importance of atherosclerotic plaque volume. Manual tools for plaque segmentation are cumbersome, and their routine implementation in clinical practice is limited. The aim of this study was to develop nomographic quantitative plaque values from a large consecutive multicenter cohort using coronary CTA. Quantitative assessment of total atherosclerotic plaque and plaque subtype volumes was performed in patients undergoing clinically indicated coronary CTA, using an Artificial Intelligence–Enabled Quantitative Coronary Plaque Analysis tool. A total of 11,808 patients were included in the analysis; their mean age was 62.7 ± 12.2 years, and 5,423 (45.9%) were women. The median total plaque volume was 223 mm
3 (IQR: 29-614 mm3 ) and was significantly higher in male participants (360 mm3 ; IQR: 78-805 mm3 ) compared with female participants (108 mm3 ; IQR: 10-388 mm3 ) (P < 0.0001). Total plaque increased with age in both male and female patients. Younger patients exhibited a higher prevalence of noncalcified plaque. The distribution of total plaque volume and its components was reported in every decile by age group and sex. The authors developed pragmatic age- and sex-stratified percentile nomograms for atherosclerotic plaque measures using findings from coronary CTA. The impact of age and sex on total plaque and its components should be considered in the risk-benefit analysis when treating patients. Artificial Intelligence–Enabled Quantitative Coronary Plaque Analysis work flows could provide context to better interpret coronary computed tomographic angiographic measures and could be integrated into clinical decision making. [Display omitted] [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
15. Derivation and validation of a novel functional FFRCT score incorporating the burden of coronary stenosis severity and flow impairment to predict clinical events.
- Author
-
Gabara, Lavinia, Hinton, Jonathan, Kira, Mohamed, Saunders, Alec, Shambrook, James, Abbas, Ausami, Leipsic, Jonathon A., Rogers, Campbell, Mullen, Sarah, Ng, Nicholas, Wilding, Sam, Douglas, Pamela S., Patel, Manesh, Fairbairn, Timothy A., Hlatky, Mark A., and Curzen, Nick
- Abstract
A score combining the burden of stenosis severity on coronary computed tomography angiography (CCTA) and flow impairment by fractional flow reserve derived from computed tomography (FFR CT) may be a better predictor of clinical events than either parameter alone. The Functional FFR CT Score (FFS) combines CCTA and FFR CT parameters in an allocated point-based system. The feasibility of the FFS was assessed in cohort of 72 stable chest pain patients with matched CCTA and FFR CT datasets. Validation was performed using 2 cohorts: (a) 4468 patients from the ADVANCE Registry to define its association with revascularization and major adverse cardiovascular events (MACE); (b) 212 patients from the FORECAST trial to determine predictors of MACE. The median calculation time for the FFS was 10 (interquartile range 6–17) seconds, with strong intra-operator and inter-operator agreement (Cohen's Kappa 0.89 (±0.37, p < 0.001) and 0.83 (±0.04, p < 0.001, respectively). The FFS correlated strongly with both the CT-SYNTAX and the Functional CT-SYNTAX scores (rS = 0.808 for both, p < 0.001). In the ADVANCE cohort the FFS had good discriminatory abilities for revascularization with an area under the curve of 0.82, 95 % confidence interval (CI) 0.81–0.84, p < 0.001. Patients in the highest FFS tertile had significantly higher rates of revascularization (61 % vs 5 %, p < 0.001) and MACE (1.9 % vs 0.5 %, p = 0.001) compared with the lowest FFS tertile. In the FORECAST cohort the FFS was an independent predictor of MACE at 9-month follow-up (hazard ratio 1.04, 95 % CI 1.01–1.08, p < 0.01). The FFS is a quick-to-calculate and reproducible score, associated with revascularization and MACE in two distinct populations of stable symptomatic patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Novel Analytics for Coronary CT Angiography: Advancing Our Understanding of Risk and Mechanisms of MI.
- Author
-
Leipsic, Jonathon A. and Chandrashekhar, Y.
- Published
- 2024
- Full Text
- View/download PDF
17. CT-Derived Plaque Physiology and Characterization: Complimentary Tools for Risk Stratification.
- Author
-
Leipsic, Jonathon A. and Tzimas, Georgios
- Abstract
[Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Prognostic implications of coronary artery calcium in the absence of coronary artery luminal narrowing
- Author
-
Cho, Iksung, ó Hartaigh, Bríain, Gransar, Heidi, Valenti, Valentina, Lin, Fay Y., Achenbach, Stephan, Berman, Daniel S., Budoff, Matthew J., Callister, Tracy Q., Al-Mallah, Mouaz H., Cademartiri, Filippo, Chinnaiyan, Kavitha, Chow, Benjamin J.W., Dunning, Allison M., DeLago, Augustin, Villines, Todd C., Hadamitzky, Martin, Hausleiter, Joerg, Leipsic, Jonathon, Shaw, Leslee J., Kaufmann, Philipp A., Cury, Ricardo C., Feuchtner, Gudrun, Kim, Yong-Jin, Maffei, Erica, Raff, Gilbert, Pontone, Gianluca, Andreini, Daniele, Chang, Hyuk-Jae, and Min, James K.
- Published
- 2017
- Full Text
- View/download PDF
19. Long-term prognostic impact of CT-Leaman score in patients with non-obstructive CAD: Results from the COronary CT Angiography EvaluatioN For Clinical Outcomes InteRnational Multicenter (CONFIRM) study
- Author
-
Andreini, Daniele, Pontone, Gianluca, Mushtaq, Saima, Gransar, Heidi, Conte, Edoardo, Bartorelli, Antonio L., Pepi, Mauro, Opolski, Maksymilian P., ó Hartaigh, Bríain, Berman, Daniel S., Budoff, Matthew J., Achenbach, Stephan, Al-Mallah, Mouaz, Cademartiri, Filippo, Callister, Tracy Q., Chang, Hyuk-Jae, Chinnaiyan, Kavitha, Chow, Benjamin J.W., Cury, Ricardo, Delago, Augustin, Hadamitzky, Martin, Hausleiter, Joerg, Feuchtner, Gudrun, Kim, Yong-Jin, Kaufmann, Philipp A., Leipsic, Jonathon, Lin, Fay Y., Maffei, Erica, Raff, Gilbert, Shaw, Leslee J., Villines, Todd C., Dunning, Allison, Marques, Hugo, Rubinshtein, Ronen, Hindoyan, Niree, Gomez, Millie, and Min, James K
- Published
- 2017
- Full Text
- View/download PDF
20. Coronary Atherosclerosis Phenotypes in Focal and Diffuse Disease.
- Author
-
Sakai, Koshiro, Mizukami, Takuya, Leipsic, Jonathon, Belmonte, Marta, Sonck, Jeroen, Nørgaard, Bjarne L., Otake, Hiromasa, Ko, Brian, Koo, Bon-kwon, Maeng, Michael, Jensen, Jesper Møller, Buytaert, Dimitri, Munhoz, Daniel, Andreini, Daniele, Ohashi, Hirofumi, Shinke, Toshiro, Taylor, Charles A., Barbato, Emanuele, Johnson, Nils P., and De Bruyne, Bernard
- Abstract
The interplay between coronary hemodynamics and plaque characteristics remains poorly understood. The aim of this study was to compare atherosclerotic plaque phenotypes between focal and diffuse coronary artery disease (CAD) defined by coronary hemodynamics. This multicenter, prospective, single-arm study was conducted in 5 countries. Patients with functionally significant lesions based on an invasive fractional flow reserve ≤0.80 were included. Plaque analysis was performed by using coronary computed tomography angiography and optical coherence tomography. CAD patterns were assessed using motorized fractional flow reserve pullbacks and quantified by pullback pressure gradient (PPG). Focal and diffuse CAD was defined according to the median PPG value. A total of 117 patients (120 vessels) were included. The median PPG was 0.66 (IQR: 0.54-0.75). According to coronary computed tomography angiography analysis, plaque burden was higher in patients with focal CAD (87% ± 8% focal vs 82% ± 10% diffuse; P = 0.003). Calcifications were significantly more prevalent in patients with diffuse CAD (Agatston score per vessel: 51 [IQR: 11-204] focal vs 158 [IQR: 52-341] diffuse; P = 0.024). According to optical coherence tomography analysis, patients with focal CAD had a significantly higher prevalence of circumferential lipid-rich plaque (37% focal vs 4% diffuse; P = 0.001) and thin-cap fibroatheroma (TCFA) (47% focal vs 10% diffuse; P = 0.002). Focal disease defined by PPG predicted the presence of TCFA with an area under the curve of 0.73 (95% CI: 0.58-0.87). Atherosclerotic plaque phenotypes associate with intracoronary hemodynamics. Focal CAD had a higher plaque burden and was predominantly lipid-rich with a high prevalence of TCFA, whereas calcifications were more prevalent in diffuse CAD. (Precise Percutaneous Coronary Intervention Plan [P3]; NCT03782688) [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
- Author
-
Hahn, Rebecca T., Lawlor, Matthew K., Davidson, Charles J., Badhwar, Vinay, Sannino, Anna, Spitzer, Ernest, Lurz, Philipp, Lindman, Brian R., Topilsky, Yan, Baron, Suzanne J., Chadderdon, Scott, Khalique, Omar K., Tang, Gilbert H.L., Taramasso, Maurizio, Grayburn, Paul A., Badano, Luigi, Leipsic, Jonathon, Lindenfeld, JoAnn, Windecker, Stephan, and Vemulapalli, Sreekanth
- Abstract
Interest in the pathophysiology, etiology, management, and outcomes of patients with tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing progressively worse outcomes associated with increasing TR severity, even after adjusting for multiple comorbidities. Historically, isolated tricuspid valve surgery has been associated with high in-hospital mortality rates, leading to the development of transcatheter treatment options. The aim of this first Tricuspid Valve Academic Research Consortium document is to standardize definitions of disease etiology and severity, as well as endpoints for trials that aim to address the gaps in our knowledge related to identification and management of patients with TR. Standardizing endpoints for trials should provide consistency and enable meaningful comparisons between clinical trials. A second Tricuspid Valve Academic Research Consortium document will focus on further defining trial endpoints and will discuss trial design options. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. Multimodality assessment of high- vs. low-gradient aortic stenosis using echocardiography and cardiac CT.
- Author
-
Zeb, Irfan, Uqaily, Raafay, Gonuguntla, Karthik, Ludhwani, Dipesh, Abdelhaleem, Ahmed, Leipsic, Jonathon, Hahn, Rebecca T., Pibarot, Philippe, Sankaramangalam, Kesavan, Kuzhandai, Dhivya, Sattar, Yasar, Raina, Sameer, Sudarshan, Balla, Kawsara, Mohammad, Hamirani, Yasmin, and Daggubati, Ramesh
- Abstract
Aortic valve area (AVA) using CT-LVOT area (AVA CT-LVOT) <1.2 cm
2 has been shown comparable to echocardiography AVA of <1.0 cm2 for severe aortic stenosis (AS). Current study evaluates how AS diagnosis will be affected when we substitute CT-LVOT with echo derived LVOT. We retrospectively studied 367 patients who underwent cardiac CTA and echocardiogram for assessment of high- and low-gradient AS (HG-AS and LG-AS). AVA CT-LVOT was derived from CT-LVOT area and echo doppler data. Three AVA CT-LVOT categories were created (<1.0, 1.0–1.2 and > 1.2 cm2 ). Outcomes were defined as composite of all-cause mortality and/or valve intervention. Median echocardiographic profiles were consistent with severe AS across three AVA CT-LVOT categories for HG-AS. HG-AS patients with AVA CT-LVOT >1.2 cm2 had larger median CT-LVOT area (5.06 cm2 ) and AVC (2917AU). Among LG-AS with AVA CT-LVOT ≤1.2 cm2 , 57% met echo criteria for low-flow LG-AS and 63% met criteria for severe AS using aortic valve calcium (AVC). Additionally, 45% with AVA CT-LVOT >1.2 cm2 had larger median CT-LVOT area (5.43 cm2 ) and AVC (2389AU). Patients with AVA CT-LVOT >1.2 cm2 and high AVC had large body surface area and were mostly characterized as severe with indexed AVA and AVC. Stroke volume index using CT-LVOT reclassified 70% of low-flow, LG-AS as normal flow, LG-AS. Composite outcomes were higher among patients with AVA CT-LVOT ≤1.2 cm2 (p < 0.01), however, with no superior net reclassification improvement compared to AVA echo <1.0 cm2 . AVA CT-LVOT ≤1.2 cm2 is a reasonable CT criterion for severe AS. Large LVOT with elevated AVC identified a severe AS phenotype despite an AVA CT-LVOT >1.2 cm2 , best characterized by indexed AVA and AVC. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
23. How early can atherosclerosis be detected by coronary CT angiography? Insights from quantitative CT analysis of serial scans in the PARADIGM trial.
- Author
-
Cardoso, Rhanderson, Choi, Andrew D., Shiyovich, Arthur, Besser, Stephanie A., Min, James K., Earls, James, Andreini, Daniele, Al-Mallah, Mouaz H., Budoff, Matthew J., Cademartiri, Filippo, Chinnaiyan, Kavitha, Choi, Jung Hyun, Chun, Eun Ju, Conte, Edoardo, Gottlieb, Ilan, Hadamitzky, Martin, Kim, Yong-Jin, Lee, Byoung Kwon, Leipsic, Jonathon A., and Maffei, Erica
- Abstract
Non-obstructing small coronary plaques may not be well recognized by expert readers during coronary computed tomography angiography (CCTA) evaluation. Recent developments in atherosclerosis imaging quantitative computed tomography (AI-QCT) enabled by machine learning allow for whole-heart coronary phenotyping of atherosclerosis, but its diagnostic role for detection of small plaques on CCTA is unknown. We performed AI-QCT in patients who underwent serial CCTA in the multinational PARADIGM study. AI-QCT results were verified by a level III experienced reader, who was blinded to baseline and follow-up status of CCTA. This retrospective analysis aimed to characterize small plaques on baseline CCTA and evaluate their serial changes on follow-up imaging. Small plaques were defined as a total plaque volume <50 mm
3 . A total of 99 patients with 502 small plaques were included. The median total plaque volume was 6.8 mm3 (IQR 3.5–13.9 mm3 ), most of which was non-calcified (median 6.2 mm3 ; 2.9–12.3 mm3 ). The median age at the time of baseline CCTA was 61 years old and 63% were male. The mean interscan period was 3.8 ± 1.6 years. On follow-up CCTA, 437 (87%) plaques were present at the same location as small plaques on baseline CCTA; 72% were larger and 15% decreased in volume. The median total plaque volume and non-calcified plaque volume increased to 18.9 mm3 (IQR 8.3–45.2 mm3 ) and 13.8 mm3 (IQR 5.7–33.4 mm3 ), respectively, among plaques that persisted on follow-up CCTA. Small plaques no longer visualized on follow-up CCTA were significantly more likely to be of lower volume, shorter in length, non-calcified, and more distal in the coronary artery, as compared with plaques that persisted at follow-up. In this retrospective analysis from the PARADIGM study, small plaques (<50 mm3 ) identified by AI-QCT persisted at the same location and were often larger on follow-up CCTA. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
24. Impact of Post-PCI FFR Stratified by Coronary Artery.
- Author
-
Collet, Carlos, Johnson, Nils P., Mizukami, Takuya, Fearon, William F., Berry, Colin, Sonck, Jeroen, Collison, Damien, Koo, Bon-Kwon, Meneveau, Nicolas, Agarwal, Shiv Kumar, Uretsky, Barry, Hakeem, Abdul, Doh, Joon-Hyung, Da Costa, Bruno R., Oldroyd, Keith G., Leipsic, Jonathon A., Morbiducci, Umberto, Taylor, Charles, Ko, Brian, and Tonino, Pim A.L.
- Abstract
Low fractional flow reserve (FFR) after percutaneous coronary intervention (PCI) has been associated with adverse clinical outcomes. Hitherto, this assessment has been independent of the epicardial vessel interrogated. This study sought to assess the predictive capacity of post-PCI FFR for target vessel failure (TVF) stratified by coronary artery. We performed a systematic review and individual patient-level data meta-analysis of randomized clinical trials and observational studies with protocol-recommended post-PCI FFR assessment. The difference in post-PCI FFR between left anterior descending (LAD) and non-LAD arteries was assessed using a random-effect models meta-analysis of mean differences. TVF was defined as a composite of cardiac death, target vessel myocardial infarction, and clinically driven target vessel revascularization. Overall, 3,336 vessels (n = 2,760 patients) with post-PCI FFR measurements were included in 9 studies. The weighted mean post-PCI FFR was 0.89 (95% CI: 0.87-0.90) and differed significantly between coronary vessels (LAD = 0.86; 95% CI: 0.85 to 0.88 vs non-LAD = 0.93; 95% CI: 0.91-0.94; P < 0.001). Post-PCI FFR was an independent predictor of TVF, with its risk increasing by 52% for every reduction of 0.10 FFR units, and this was mainly driven by TVR. The predictive capacity for TVF was poor for LAD arteries (AUC: 0.52; 95% CI: 0.47-0.58) and moderate for non-LAD arteries (AUC: 0.66; 95% CI: 0.59-0.73; LAD vs non-LAD arteries, P = 0.005). The LAD is associated with a lower post-PCI FFR than non-LAD arteries, emphasizing the importance of interpreting post-PCI FFR on a vessel-specific basis. Although a higher post-PCI FFR was associated with improved prognosis, its predictive capacity for events differs between the LAD and non-LAD arteries, being poor in the LAD and moderate in the non-LAD vessels. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. When Does a Calcium Score Equate to Secondary Prevention?: Insights From the Multinational CONFIRM Registry.
- Author
-
Budoff, Matthew J., Kinninger, April, Gransar, Heidi, Achenbach, Stephan, Al-Mallah, Mouaz, Bax, Jeroen J., Berman, Daniel S., Cademartiri, Filippo, Callister, Tracy Q., Chang, Hyuk-Jae, Chow, Benjamin J.W., Cury, Ricardo C., Feuchtner, Gudrun, Hadamitzky, Martin, Hausleiter, Joerg, Kaufmann, Philipp A., Leipsic, Jonathon, Lin, Fay Y., Kim, Yong-Jin, and Marques, Hugo
- Published
- 2023
- Full Text
- View/download PDF
26. Transcatheter Mitral Valve-in-Valve Replacement in the Presence of Pannus: A Word of Caution.
- Author
-
Jelisejevas, Julius, Husain, Ali, Dundas, James, Chiang, Brian, Akodad, Mariama, Zaky, Fady, Sathananthan, Gnalini, Wood, David A., Leipsic, Jonathon A., Blanke, Philipp, Sathananthan, Janarthanan, Sellers, Stephanie L., Meier, David, and Webb, John G.
- Published
- 2024
- Full Text
- View/download PDF
27. Transcatheter Mitral Valve Replacement: 5 Years Later.
- Author
-
Husain, Ali, Meier, David, Dundas, James, Akodad, Mariama, Jelisejevas, Julius, Zaky, Fady, Moss, Robert, Sathananthan, Gnalini, Sellers, Stephanie L., Leipsic, Jonathon A., Blanke, Philipp, Wood, David A., Sathananthan, Janarthanan, Boone, Robert, and Webb, John G.
- Published
- 2023
- Full Text
- View/download PDF
28. Predicted vs Observed Valve to Coronary Distance in Valve-in-Valve TAVR: A Computed Tomography Study.
- Author
-
Tzimas, Georgios, Akodad, Mariama, Meier, David, Duchscherer, Jade, Kalk, Kelsey, Everett, Russell J., Haidari, Oliver, Chuang, Ming-Yu A., Sellers, Stephanie L., Dvir, Danny, Sathananthan, Janarthanan, Leipsic, Jonathon A., Webb, John G., and Blanke, Philipp
- Abstract
Preprocedural computed tomography (CT) workup with assessment of virtual transcatheter heart valve-to-coronary ostia (VTC) distance and transcatheter heart valve-to-sinus (VTS) distances is recommended to assess the risk of coronary obstruction following valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR). The authors sought to investigate the agreement of predicted VTC and VTS distances and observed post-TAVR anatomy on CT and their relationship with transcatheter heart valve (THV) expansion and deployment conditions. Fifty-one patients who underwent a balloon-expandable ViV procedure were included in this study. The expansion of the THV stent frame was evaluated at 4 levels: THV inflow, surgical heart valve (SHV) sewing ring, SHV outflow, and THV outflow. Assessment of the VTC/VTS distances was performed on the pre-TAVR CT, and THV-to-coronary ostia and THV-to-sinus distances were assessed on the post-TAVR CT. Following the ViV procedure, the THV stent frame flared toward the outflow but was generally underexpanded at all levels, particularly at the SHV sewing ring level. Postdilatation impacted the extent of THV expansion, resulting in greater expansion than nominal balloon filling at all 4 THV levels (P < 0.001). Observed THV-to-coronary ostia distances were systematically larger than predicted by the VTC distance (mean difference 1.25 ±1.28 mm) in patients with nominal balloon filling but systematically smaller in case of postdilatation (mean difference −0.45 ± 0.52 mm). A similar relationship was observed between VTS and THV-to-sinus distance measurements. With nominal balloon filling, VTC and VTS distances underestimate postprocedural distances due to THV frame underexpansion. However, postdilatation may lead to distances smaller than predicted due to THV overexpansion at the outflow level. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care.
- Author
-
Bienstock, Solomon, Lin, Fay, Blankstein, Ron, Leipsic, Jonathon, Cardoso, Rhanderson, Ahmadi, Amir, Gelijns, Annetine, Patel, Krishna, Baldassarre, Lauren A., Hadley, Michael, LaRocca, Gina, Sanz, Javier, Narula, Jagat, Chandrashekhar, Y.S., Shaw, Leslee J., and Fuster, Valentin
- Abstract
The diagnostic evaluation of coronary artery disease is undergoing a dramatic transformation with a new focus on atherosclerotic plaque. This review details the evidence needed for effective risk stratification and targeted preventive care based on recent advances in automated measurement of atherosclerosis from coronary computed tomography angiography (CTA). To date, research findings support that automated stenosis measurement is reasonably accurate, but evidence on variability by location, artery size, or image quality is unknown. The evidence for quantification of atherosclerotic plaque is unfolding, with strong concordance reported between coronary CTA and intravascular ultrasound measurement of total plaque volume (r >0.90). Statistical variance is higher for smaller plaque volumes. Limited data are available on how technical or patient-specific factors result in measurement variability by compositional subgroups. Coronary artery dimensions vary by age, sex, heart size, coronary dominance, and race and ethnicity. Accordingly, quantification programs excluding smaller arteries affect accuracy for women, patients with diabetes, and other patient subsets. Evidence is unfolding that quantification of atherosclerotic plaque is useful to enhance risk prediction, yet more evidence is required to define high-risk patients across varied populations and to determine whether such information is incremental to risk factors or currently used coronary computed tomography techniques (eg, coronary artery calcium scoring or visual assessment of plaque burden or stenosis). In summary, there is promise for the utility of coronary CTA quantification of atherosclerosis, especially if it can lead to targeted and more intensive cardiovascular prevention, notably for those patients with nonobstructive coronary artery disease and high-risk plaque features. The new quantification techniques available to imagers must not only provide sufficient added value to improve patient care, but also add minimal and reasonable cost to alleviate the financial burden on our patients and the health care system. [Display omitted] • Significant advances in coronary CTA now allow for detailed measurement of atherosclerosis and could be very helpful to guide preventive care, including automated quantification of stenosis severity and atherosclerotic plaque and its compositional subgroups. • Coronary artery dimensions vary by age, sex, heart size, coronary dominance, and race and ethnicity. Accordingly, quantification programs excluding smaller arteries affect accuracy for women, patients with diabetes, and other patient subsets. • Limited prognostic evidence is available to report on the thresholds for high-risk status on the basis of newer automated measurements of atherosclerotic plaque. • The promise of automation with coronary CTA enhances the feasibility of imaging of atherosclerosis and the possibility of coronary CTA-guided preventive care. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. TAVR in Bicuspid Aortic Stenosis: Current Evidence and Proposal for a Randomized Controlled Trial Design.
- Author
-
Nuyens, Philippe, De Backer, Ole, Sathananthan, Janarthanan, Højsgaard Jørgensen, Troels, Treede, Hendrik, Leipsic, Jonathon A., Bax, Jeroen J., Webb, John G., Mehran, Roxana, Chen, Mao, Reardon, Michael, Leon, Martin B., and Søndergaard, Lars
- Published
- 2023
- Full Text
- View/download PDF
31. Bioprosthetic Valve Remodeling in Nonfracturable Surgical Valves: Impact on THV Expansion and Hydrodynamic Performance.
- Author
-
Meier, David, Puehler, Thomas, Lutter, Georg, Shen, Carol, Lai, Althea, Gill, Hacina, Akodad, Mariama, Tzimas, Georgios, Chhatriwalla, Adnan, Allen, Keith B., Blanke, Philipp, Payne, Geoffrey W., Wood, David A., Leipsic, Jonathon A., Webb, John G., Sellers, Stephanie L., and Sathananthan, Janarthanan
- Abstract
There are limited data on the effect of bioprosthetic valve remodeling (BVR) on transcatheter heart valve (THV) expansion and function following valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) in a nonfracturable surgical heart valve (SHV). This study sought to assess the impact of BVR of nonfracturable SHVs on THVs after VIV implantation. VIV TAVR was performed using 23-mm SAPIEN3 (S3, Edwards Lifesciences) or 23/26-mm Evolut Pro (Medtronic) THVs implanted in 21/23-mm Trifecta (Abbott Structural Heart) and 21/23-mm Hancock (Medtronic) SHVs with BVR performed with a noncompliant TRUE balloon (Bard Peripheral Vascular Inc). Hydrodynamic assessment was performed, and multimodality imaging including micro–computed tomography was performed before and after BVR to assess THV and SHV expansion. BVR resulted in limited improvement of THV expansion. The largest gain in expansion was observed for the S3 in the 21-mm Trifecta with up to a 12.7% increase in expansion at the outflow of the valve. Minimal change was observed at the level of the sewing ring. The Hancock was less amenable to BVR with lower final expansion dimensions than the Trifecta. BVR also resulted in notable surgical post flaring of up to 17.6°, which was generally more marked with the S3 than with the Evolut Pro. Finally, BVR resulted in very limited improvement in hydrodynamic function. Severe pinwheeling was observed with the S3, which improved slightly but persisted despite BVR. When performing VIV TAVR inside a Trifecta and Hancock SHV, BVR had a limited impact on THV expansion and resulted in SHV post flaring with unknown consequences on coronary obstruction risk and long-term THV function. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. Managing Patients With Moderate Aortic Stenosis.
- Author
-
Stassen, Jan, Ewe, See Hooi, Pio, Stephan M., Pibarot, Philippe, Redfors, Bjorn, Leipsic, Jonathon, Genereux, Philippe, Van Mieghem, Nicolas M., Kuneman, Jurrien H., Makkar, Raj, Hahn, Rebecca T., Playford, David, Marsan, Nina Ajmone, Delgado, Victoria, Ben-Yehuda, Ori, Leon, Martin B., and Bax, Jeroen J.
- Abstract
Current guidelines recommend that clinical surveillance for patients with moderate aortic stenosis (AS) and aortic valve replacement (AVR) may be considered if there is an indication for coronary revascularization. Recent observational studies, however, have shown that moderate AS is associated with an increased risk of cardiovascular events and mortality. Whether the increased risk of adverse events is caused by associated comorbidities, or to the underlying moderate AS itself, is incompletely understood. Similarly, which patients with moderate AS need close follow-up or could potentially benefit from early AVR is also unknown. In this review, the authors provide a comprehensive overview of the current published reports on moderate AS. They first provide an algorithm that helps to diagnose moderate AS correctly, especially when discordant grading is observed. Although the traditional focus of AS assessment has been on the valve, it is increasingly acknowledged that AS is not only a disease of the aortic valve but also of the ventricle. The authors therefore discuss how multimodality imaging can help to evaluate the left ventricular remodeling response and improve risk stratification in patients with moderate AS. Finally, they summarize current evidence on the management of moderate AS and highlight ongoing trials on AVR in moderate AS. [Display omitted] • Moderate AS is associated with a high risk of adverse cardiovascular events, including death. • DSE and cardiac CT can help to improve an accurate diagnosis of moderate AS. • Multimodality imaging can help to evaluate the left ventricular remodeling response caused by the underlying moderate AS. • Randomized controlled trials are ongoing to evaluate whether AVR can improve outcomes in patients with moderate AS. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. Integration of fractional flow reserve derived from CT into clinical practice.
- Author
-
Takagi, Hidenobu, Ihdayhid, Abdul Rahman, and Leipsic, Jonathon A.
- Abstract
Fractional flow reserve (FFR) is currently considered as the gold standard for revascularization decision-making in patients with stable coronary artery disease (CAD). The application of computational fluid dynamics to coronary computed tomography (CT) angiography (CCTA) enables calculation of FFR without additional testing, radiation exposure, contrast medium injection, and hyperemia (FFR CT). Although multiple diagnostic and clinical studies have enriched the scientific evidence, it is still challenging to integrate FFR CT into clinical practice. Both meticulous scientific backgrounds and precise anatomical data derived from CCTA are fundamental for FFR CT computation, and there are numerous factors impacting on FFR CT calculation and interpretation: coronary artery stenosis, calcium, atherosclerosis, luminal volume, and left ventricular myocardial mass. Further, there is a gap that clinicians using FFR CT need to recognize in interpretation of FFR CT results between diagnostic studies and clinical studies. In this review, we summarize multiple evidence related to FFR CT computation and interpretation to refine the FFR CT strategy in patients with stable CAD. [Display omitted] • Fractional flow reserve (FFR) is the gold standard for revascularization in patients with stable coronary artery disease. • Application of computational fluid dynamics to computed tomography (CT) enables non-invasive calculation of FFR (FFR CT). • Numerous factors impact on FFR CT calculation as well as invasive FFR. • There is a gap in interpretation of FFR CT results between diagnostic studies and clinical studies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. Contemporary Chest Pain Evaluation: The Australian Case for Cardiac CT
- Author
-
Ihdayhid, Abdul Rahman, Lan, Nick S.R., Figtree, Gemma A., Patel, Sanjay, Arnott, Clare, Hamilton-Craig, Christian, Psaltis, Peter J., Leipsic, Jonathon, Fairbairn, Timothy, Wahi, Sudhir, Hillis, Graham S., Rankin, James M., Dwivedi, Girish, and Nicholls, Stephen J.
- Published
- 2023
- Full Text
- View/download PDF
35. †Age- and Sex-Specific Nomographic CT Quantitative Plaque Data From a Large International Cohort.
- Author
-
Tzimas, George, Gulsin, Gaurav, ChB, MB, Ng, Nicholas, Mullen, Sarah, Sellers, Stephanie, Blanke, Philipp, and Leipsic, Jonathon
- Subjects
BLOOD vessels ,COMPUTED tomography ,ARTIFICIAL intelligence ,SEX distribution ,AGE distribution ,EVALUATION of medical care ,CONFERENCES & conventions ,CORONARY artery disease ,CORONARY angiography - Abstract
With growing adoption of coronary computed tomographic angiography (CTA), there is increasing evidence for and interest in the prognostic importance of atherosclerotic plaque volume. Manual tools for plaque segmentation are cumbersome, and their routine implementation in clinical practice is limited. The aim of this study was to develop nomographic quantitative plaque values from a large consecutive multicenter cohort using coronary CTA. Quantitative assessment of total atherosclerotic plaque and plaque subtype volumes was performed in patients undergoing clinically indicated coronary CTA, using an Artificial Intelligence-Enabled Quantitative Coronary Plaque Analysis tool. A total of 11,808 patients were included in the analysis; their mean age was 62.7±12.2 years, and 5,423 (45.9%) were women. The median total plaque volume was 223 mm3 (IQR: 29-614 mm3) and was significantly higher in male participants (360 mm3; IQR: 78-805 mm3) compared with female participants (108 mm3; IQR: 10-388 mm3)(P < 0.0001). Total plaque increased with age in both male and female patients. Younger patients exhibited a higher prevalence of noncalcified plaque. The distribution of total plaque volume and its components was reported in every decile by age group and sex. The authors developed pragmatic age- and sex-stratified percentile nomograms for atherosclerotic plaque measures using findings from coronary CTA. The impact of age and sex on total plaque and its components should be considered in the risk-benefit analysis when treating patients. Artificial Intelligence-Enabled Quantitative Coronary Plaque Analysis work flows could provide context to better interpret coronary computed tomographic angiographic measures and could be integrated into clinical decision making. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Bioprosthetic Valve Fracture 3 Years Post–Valve-in-Valve TAVR.
- Author
-
Husain, Ali, Meier, David, Dundas, James, Akodad, Mariama, Jelisejevas, Julius, Zaky, Fady, Wood, David A., Sellers, Stephanie L., Leipsic, Jonathon A., Blanke, Philipp, Sathananthan, Janarthanan, and Webb, John G.
- Published
- 2023
- Full Text
- View/download PDF
37. Patterns and Structure of Calcification in Aortic Stenosis: An Approach on Contrast-Enhanced CT Images.
- Author
-
Abdelkhalek, Mohamed, Daeian, MohammadAli, Chavarria, Jorge, Sellers, Stephanie, Gulsin, Gaurav, Leipsic, Jonathon, Sheth, Tej, and Keshavarz-Motamed, Zahra
- Published
- 2023
- Full Text
- View/download PDF
38. Accuracy of a virtual PCI planner based on coronary CT angiography in calcific lesions.
- Author
-
Belmonte, Marta, Maeng, Michael, Collet, Carlos, Norgaard, Bjarne L., Otake, Hiromasa, Ko, Brian, Koo, Bon-Kwon, Mizukami, Takuya, Updegrove, Adam, Barbato, Emanuele, De Bruyne, Bernard, Leipsic, Jonathon, Taylor, Charles, Andreini, Daniele, and Sonck, Jeroen
- Published
- 2023
- Full Text
- View/download PDF
39. Clinical and Coronary Plaque Predictors of Atherosclerotic Nonresponse to Statin Therapy.
- Author
-
van Rosendael, Sophie E., van den Hoogen, Inge J., Lin, Fay Y., Andreini, Daniele, Al-Mallah, Mouaz H., Budoff, Matthew J., Cademartiri, Filippo, Chinnaiyan, Kavitha, Choi, Jung Hyun, Conte, Edoardo, Marques, Hugo, de Araújo Gonçalves, Pedro, Gottlieb, Ilan, Hadamitzky, Martin, Leipsic, Jonathon A., Maffei, Erica, Pontone, Gianluca, Raff, Gilbert L., Shin, Sanghoon, and Kim, Yong-Jin
- Abstract
Statins reduce the incidence of major cardiovascular events, but residual risk remains. The study examined the determinants of atherosclerotic statin nonresponse. This study aimed to investigate factors associated with statin nonresponse-defined atherosclerosis progression in patients treated with statins. The multicenter PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) registry included patients who underwent serial coronary computed tomography angiography ≥2 years apart, with whole-heart coronary tree quantification of vessel, lumen, and plaque, and matching of baseline and follow-up coronary segments and lesions. Patients with statin use at baseline and follow-up coronary computed tomography angiography were included. Atherosclerotic statin nonresponse was defined as an absolute increase in percent atheroma volume (PAV) of 1.0% or more per year. Furthermore, a secondary endpoint was defined by the additional requirement of progression of low-attenuation plaque or fibro-fatty plaque. The authors included 649 patients (age 62.0 ± 9.0 years, 63.5% male) on statin therapy and 205 (31.5%) experienced atherosclerotic statin nonresponse. Age, diabetes, hypertension, and all atherosclerotic plaque features measured at baseline scan (high-risk plaque [HRP] features, calcified and noncalcified PAV, and lumen volume) were significantly different between patients with and without atherosclerotic statin nonresponse, whereas only diabetes, number of HRP features, and noncalcified and calcified PAV were independently associated with atherosclerotic statin nonresponse (odds ratio [OR]: 1.41 [95% CI: 0.95-2.11], OR: 1.15 [95% CI: 1.09-1.21], OR: 1.06 [95% CI: 1.02-1.10], OR: 1.07 [95% CI: 1.03-1.12], respectively). For the secondary endpoint (N = 125, 19.2%), only noncalcified PAV and number of HRP features were the independent determinants (OR: 1.08 [95% CI: 1.03-1.13] and OR: 1.21 [95% CI: 1.06-1.21], respectively). In patients treated with statins, baseline plaque characterization by plaque burden and HRP is associated with atherosclerotic statin nonresponse. Patients with the highest plaque burden including HRP were at highest risk for plaque progression, despite statin therapy. These patients may need additional therapies for further risk reduction. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
40. The journal of cardiovascular computed tomography: A year in review: 2022.
- Author
-
Pontone, Gianluca, Mushtaq, Saima, Al'Aref, Subhi J., Andreini, Daniele, Baggiano, Andrea, Canan, Arzu, Cavalcante, Joao L., Chelliah, Anjali, Chen, Marcus, Choi, Andrew, Damini, Dey, De Cecco, Carlo Nicola, Farooqi, Kanwal M., Ferencik, Maros, Feuchtner, Gudrun, Hecht, Harvey, Gransar, Heidi, Kolossváry, Márton, Leipsic, Jonathon, and Lu, Michael T.
- Abstract
This review aims to summarize key articles published in the Journal of Cardiovascular Computed Tomography (JCCT) in 2022, focusing on those that had the most scientific and educational impact. The JCCT continues to expand; the number of submissions, published manuscripts, cited articles, article downloads, social media presence, and impact factor continues to grow. The articles selected by the Editorial Board of the JCCT in this review highlight the role of cardiovascular computed tomography (CCT) to detect subclinical atherosclerosis, assess the functional relevance of stenoses, and plan invasive coronary and valve procedures. A section is dedicated to CCT in infants and other patients with congenital heart disease, in women, and to the importance of training in CT. In addition, we highlight key consensus documents and guidelines published in JCCT last year. The Journal values the tremendous work by authors, reviewers, and editors to accomplish these contributions. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
41. First-in-Human Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in Transcatheter Aortic Valve Replacement.
- Author
-
Dvir, Danny, Leon, Martin B., Abdel-Wahab, Mohamed, Unbehaun, Axel, Kodali, Susheel, Tchetche, Didier, Pibarot, Philippe, Leipsic, Jonathon, Blanke, Philipp, Gerckens, Ulrich, Manoharan, Ganesh, Harari, Emanuel, Hellou, Elias, Wolak, Arik, Ben-Assa, Eyal, Jubeh, Rami, Shuvy, Mony, Koifman, Edward, Klein, Christoph, and Kempfert, Joerg
- Abstract
Coronary artery obstruction is a life-threatening complication of transcatheter aortic valve replacement (TAVR) procedures. Current preventive strategies are suboptimal. The aim of this study was to describe bench testing and clinical experience with a novel device that splits valve leaflets that are at risk for causing coronary obstruction after TAVR, allowing normal coronary flow. The ShortCut device was initially tested in vitro and preclinically in a porcine model for functionality and safety. The device was subsequently offered to patients at elevated risk for coronary obstruction. Risk for coronary obstruction was based on computed tomography–based anatomical characteristics. Procedure success was determined as patient survival at 30 days with a functioning new valve, without stroke or coronary obstruction. Following a successful completion of bench testing and preclinical trial, the device was used in 8 patients with failed bioprosthetic valves (median age 81 years; IQR: 72-85 years; 37.5% man) at 2 medical centers. A total of 11 leaflets were split: 5 patients (63.5%) were considered at risk for left main obstruction alone, and 3 patients (37.5%) were at risk for double coronary obstruction. All patients underwent successful TAVR without evidence of coronary obstruction. All patients were discharged from the hospital in good clinical condition, and no adverse neurologic events were noted. Procedure success was 100%. Evaluation of the first dedicated transcatheter leaflet-splitting device shows that the device can successfully split degenerated bioprosthetic valve leaflets. The procedure was safe and successfully prevented coronary obstruction in patients at risk for this complication following TAVR. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
42. Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial.
- Author
-
Reynolds, Harmony R., Diaz, Ariel, Cyr, Derek D., Shaw, Leslee J., Mancini, G.B. John, Leipsic, Jonathon, Budoff, Matthew J., Min, James K., Hague, Cameron J., Berman, Daniel S., Chaitman, Bernard R., Picard, Michael H., Hayes, Sean W., Scherrer-Crosbie, Marielle, Kwong, Raymond Y., Lopes, Renato D., Senior, Roxy, Dwivedi, Sudhanshu K., Miller, Todd D., and Chow, Benjamin J.W.
- Abstract
Ischemia with nonobstructive coronary arteries (INOCA) is common clinically, particularly among women, but its prevalence among patients with at least moderate ischemia and the relationship between ischemia severity and non-obstructive atherosclerosis severity are unknown. The authors investigated predictors of INOCA in enrolled, nonrandomized participants in ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches), sex differences, and the relationship between ischemia and atherosclerosis in patients with INOCA. Core laboratories independently reviewed screening noninvasive stress test results (nuclear imaging, echocardiography, magnetic resonance imaging or nonimaging exercise tolerance testing), and coronary computed tomography angiography (CCTA), blinded to results of the screening test. INOCA was defined as all stenoses <50% on CCTA in a patient with moderate or severe ischemia on stress testing. INOCA patients, who were excluded from randomization, were compared with randomized participants with ≥50% stenosis in ≥1 vessel and moderate or severe ischemia. Among 3,612 participants with core laboratory-confirmed moderate or severe ischemia and interpretable CCTA, 476 (13%) had INOCA. Patients with INOCA were younger, were predominantly female, and had fewer atherosclerosis risk factors. For each stress testing modality, the extent of ischemia tended to be less among patients with INOCA, particularly with nuclear imaging. There was no significant relationship between severity of ischemia and extent or severity of nonobstructive atherosclerosis on CCTA. On multivariable analysis, female sex was independently associated with INOCA (odds ratio: 4.2 [95% CI: 3.4-5.2]). Among participants enrolled in ISCHEMIA with core laboratory-confirmed moderate or severe ischemia, the prevalence of INOCA was 13%. Severity of ischemia was not associated with severity of nonobstructive atherosclerosis. (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches [ISCHEMIA]; NCT01471522) [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
43. Clinical and Echocardiographic Characteristics of Flow-Based Classification Following Balloon-Expandable Transcatheter Heart Valve in PARTNER Trials.
- Author
-
Akinmolayemi, Oludamilola, Ozdemir, Denizhan, Pibarot, Philippe, Zhao, Yanglu, Leipsic, Jonathon, Douglas, Pamela S., Jaber, Wael A., Weissman, Neil J., Blanke, Philipp, and Hahn, Rebecca T.
- Abstract
Current expected normal echocardiographic measures of transcatheter heart valve (THV) function were derived from pooled cohorts of the randomized trials; however, THV function by flow state before or following transcatheter aortic valve replacement (TAVR) has not been previously reported. This study sought to assess the expected normal echocardiographic hemodynamics for the balloon-expandable THV grouped by stroke volume index (SVI). Patients with severe aortic stenosis enrolled in PARTNER (Placement of Aortic Transcatheter Valves) 1 (high/extreme surgical risk), PARTNER 2 (intermediate surgical risk), or PARTNER 3 (low surgical risk) trials with complete core laboratory echocardiography were included. Patients were grouped by low-flow (SVI LOW <35 mL/m
2 ) and normal-flow (SVI NORMAL ≥35 mL/m2 ). Mean gradient, effective orifice area (EOA), and Doppler velocity index (DVI) were collected at baseline and at 30 days post-TAVR. Prosthesis-patient mismatch (PPM) was both calculated and predicted from normative data, using defined criteria. In the entire population (N = 4,991), mean age was 81.8 years, 58% of patients were male, and 42% had low flow. Compared with patients with baseline SVI NORMAL , those with SVI LOW were more likely to be male; have more comorbidities; and lower left ventricular ejection fraction, mean gradient, and EOA. Post-TAVR, SVI LOW increased to SVI NORMAL in 17.3% and SVI NORMAL decreased to SVI LOW in 12.3% of patients. Using baseline SVI, follow-up EOA, mean gradient, and DVI for patients with SVI LOW tended to be lower than for patients with SVI NORMAL. Using the post-TAVR SVI, follow-up EOA, mean gradient, and DVI were significantly lower for patients with SVI LOW than for those with SVI NORMAL (P < 0.001 for all). The incidence of calculated, but not predicted, severe PPM was higher in patients with low flow than it was in patients with normal flow, suggesting pseudo-PPM in the presence of low flow. This study demonstrates that flow affects THV hemodynamics and both baseline and follow-up SVI should be considered when predicting THV hemodynamics prior to TAVR, as well as assessing valve function following valve implantation. [Display omitted] [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
44. Computed tomography imaging for subclinical leaflet thrombosis following surgical and transcatheter aortic valve replacement.
- Author
-
Rashid, Hashrul N., Rajani, Ronak, Leipsic, Jonathon, Maurovitch-Horvat, Pál, Patterson, Tiffany, Redwood, Simon, Lee, Jack, Hurrell, Harriet, Nicholls, Stephen J., Nasis, Arthur, Seneviratne, Sujith, Cameron, James D., Prendergast, Bernard, and Gooley, Robert P.
- Abstract
Subclinical leaflet thrombosis (LT) may occur following surgical and transcatheter aortic valve replacement. Computed tomography (CT) has become an established imaging modality to diagnose subclinical LT following bioprosthetic aortic valve replacement. Even so, there is a limited (but growing) experience in utilizing CT imaging for this indication. This review emphasizes a systematic approach to acquiring and analysing CT imaging for subclinical LT, highlighting evidence surrounding clinical sequelae of subclinical LT and anti-thrombotic implications following diagnosis. Graphical Abstract [Display omitted] Caption: Computed tomography (CT) is an established imaging modality to diagnose subclinical leaflet thrombosis following transcatheter aortic valve replacement (TAVR). The extent of HALT should be graded according to the degree of leaflet thickening along the curvilinear surface of the leaflet (upper panel); Grade 1 (≤25%), Grade 2 (>25–50%), Grade 3 (>50–75%), and Grade 4 (>75%). Routine CT following TAVR is currently not recommended but should be strongly considered in (lower left panel) patients presenting with cryptogenic stroke or new valvular dysfunction (such as significant stenosis or regurgitation). It is essential to ensure CT images are acquired correctly (lower middle panel) by adjusting the CT tube potential settings to the patient by taking into account patient's size and type of prosthesis, adequate heart rate control (below 70 beats per minute), prospective electrocardiogram (ECG) gated imaging (complete R-R interval) and contrast bolus tracking. The CT images should be analysed (lower right panel) for the presence of hypo-attenuated leaflet thickening (HALT) in diastole. The presence of HALT should prompt an assessment for reduced leaflet motion (RELM) during systole and with four-dimensional volume rendering when available. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. Hybrid Approach Using the Cusp-Overlap Technique for Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve.
- Author
-
Akodad, Mariama, Blanke, Philipp, Nestelberger, Thomas, Alosail, Abdulmajeed, Chatfield, Andrew G., Chuang, Ming-Yu A., Leipsic, Jonathon A., Tzimas, Georgios, Lounes, Youcef, Meier, David, Sathananthan, Janarthanan, Wood, David A., and Webb, John G.
- Abstract
The cusp-overlap (CO) technique has recently been advocated and is being increasingly adopted for self-expandable transcatheter heart valve (THV) implantation. The aim of this study was to evaluate the feasibility, implantation depth, and outcomes of the CO technique for the balloon-expandable SAPIEN 3 THV. The CO technique was used in consecutive patients undergoing balloon-expandable THV implantation at one center between April 2021 and March 2022. Optimal fluoroscopic angles were determined from preprocedural computed tomography and confirmed on predeployment angiography. The THV radiolucent line was positioned 2 to 4 mm below the noncoronary cusp in the CO view, and positioning was confirmed in the 3-cusp view. Postdeployment THV implantation depth was assessed in both views. One-month outcomes were assessed using Valve Academic Research Consortium 3 criteria. Among 137 patients eligible for the CO technique, the CO view was not used because of unfavorable ergonomics in 27 patients (26.5%) and hemodynamic instability in 8 patients (7.8%). Among 102 patients, the mean age was 81.1 ± 6.6 years, the mean Society of Thoracic Surgeons score was 3.3% ± 2.2%, and 64.7% were men. The mean measured THV implantation depth was 3.0 ± 1.4 mm in the CO view and 2.5 ± 1.4 mm in the 3-cusp view. At 1-month follow-up, 1 patient (1.0%) had died, 1 (1.0%) had had a stroke, and 7 (6.8%) had undergone permanent pacemaker implantation. The CO technique is feasible and safe and may facilitate more accurate balloon-expandable THV positioning, especially when deep implantation needs to be avoided. Further studies are required to explore potential reduction in atrioventricular conduction block, pacemakers, or paravalvular regurgitation. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
46. Aortic Annulus S-Curve: Implications for Transcatheter Aortic Valve Replacement and Related Procedures, Part 1.
- Author
-
Zgheib, Ali, Campens, Laurence, Abualsaud, Ali, Al Isma'ili, Abdullah, Barbanti, Marco, Dvir, Danny, Gada, Hemal, Granada, Juan F., Latib, Azeem, Leipsic, Jonathon, Maisano, Francesco, Martucci, Giuseppe, Medina de Chazal, Horacio A., Modine, Thomas, Mylotte, Darren, Prendergast, Bernard, Sawaya, Fadi, Spaziano, Marco, Tang, Gilbert, and Theriault-Lauzier, Pascal
- Abstract
Most transcatheter aortic valve replacement–related procedures (eg, transcatheter aortic valve replacement implantation depth, commissural alignment, coronary access, bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction, paravalvular leak closure) require an optimal fluoroscopic viewing angle located somewhere along the aortic annulus S-curve. Chamber views, coronary cusp and coronary anatomy, can be understood along the aortic annulus S-curve. A better understanding of the optimal fluoroscopic viewing angles along the S-curve may translate into increased operator confidence and improved safety and efficacy while reducing procedural time, radiation dose, contrast volume, and complication rates. [Display omitted] • Aortic annulus S-curve and optimal projection aid in guiding TAVR and related procedures. • The aim of this manuscript is to present an in-depth insight of aortic annulus S-curve in TAVR. • Refinement in C-arm equipment should aim to optimize optimal fluoroscopic projections. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
47. Atrial Functional Mitral Regurgitation: A JACC: Cardiovascular Imaging Expert Panel Viewpoint.
- Author
-
Zoghbi, William A., Levine, Robert A., Flachskampf, Frank, Grayburn, Paul, Gillam, Linda, Leipsic, Jonathon, Thomas, James D., Kwong, Raymond Y., Vandervoort, Pieter, and Chandrashekhar, Y.
- Abstract
Functional or secondary mitral regurgitation (MR) is associated with increased cardiovascular morbidity and mortality. Mechanistically, secondary MR is attributable to an imbalance between mitral leaflet tethering and closure forces, leading to poor coaptation. The pathophysiology of functional MR is most often the result of abnormalities in left ventricular function and remodeling, seen in ischemic or nonischemic conditions. Less commonly and more recently recognized is the scenario in which left ventricular geometry and function are preserved, the culprit being mitral annular enlargement associated with left atrial dilatation, termed atrial functional mitral regurgitation (AFMR). This most commonly occurs in the setting of chronic atrial fibrillation or heart failure with preserved ejection fraction. There is variability in the published reports and in current investigations as to the definition of AFMR. This paper reviews the pathophysiology of AFMR and focus on the need for a collective definition of AFMR to facilitate consistency in reported data and enhance much-needed research into outcomes and treatment strategies in AFMR. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
48. CAD-RADS™ 2.0 – 2022 Coronary Artery Disease-Reporting and Data System: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology...
- Author
-
Cury, Ricardo C., Leipsic, Jonathon, Abbara, Suhny, Achenbach, Stephan, Berman, Daniel, Bittencourt, Marcio, Budoff, Matthew, Chinnaiyan, Kavitha, Choi, Andrew D., Ghoshhajra, Brian, Jacobs, Jill, Koweek, Lynne, Lesser, John, Maroules, Christopher, Rubin, Geoffrey D., Rybicki, Frank J., Shaw, Leslee J., Williams, Michelle C., Williamson, Eric, and White, Charles S.
- Abstract
Coronary Artery Disease Reporting and Data System (CAD-RADS) was created to standardize reporting system for patients undergoing coronary CT angiography (CCTA) and to guide possible next steps in patient management. The goal of this updated 2022 CAD-RADS 2.0 is to improve the initial reporting system for CCTA by considering new technical developments in cardiac CT, including data from recent clinical trials and new clinical guidelines. The updated CAD-RADS classification will follow an established framework of stenosis, plaque burden, and modifiers, which will include assessment of lesion-specific ischemia using CT fractional-flow-reserve (CT-FFR) or myocardial CT perfusion (CTP), when performed. Similar to the method used in the original CAD-RADS version, the determinant for stenosis severity classification will be the most severe coronary artery luminal stenosis on a per-patient basis, ranging from CAD-RADS 0 (zero) for absence of any plaque or stenosis to CAD-RADS 5 indicating the presence of at least one totally occluded coronary artery. Given the increasing data supporting the prognostic relevance of coronary plaque burden, this document will provide various methods to estimate and report total plaque burden. The addition of P1 to P4 descriptors are used to denote increasing categories of plaque burden. The main goal of CAD-RADS, which should always be interpreted together with the impression found in the report, remains to facilitate communication of test results with referring physicians along with suggestions for subsequent patient management. In addition, CAD-RADS will continue to provide a framework of standardization that may benefit education, research, peer-review, artificial intelligence development, clinical trial design, population health and quality assurance with the ultimate goal of improving patient care. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
49. Pre-procedural planning of coronary revascularization by cardiac computed tomography: An expert consensus document of the Society of Cardiovascular Computed Tomography.
- Author
-
Andreini, Daniele, Collet, Carlos, Leipsic, Jonathon, Nieman, Koen, Bittencurt, Marcio, De Mey, Johan, Buls, Nico, Onuma, Yoshinobu, Mushtaq, Saima, Conte, Edoardo, Bartorelli, Antonio L., Stefanini, Giulio, Sonck, Jeroen, Knaapen, Paul, Ghoshhajra, Brian, and Serruys, Patrick
- Abstract
Coronary CT angiography (CCTA) demonstrated high diagnostic accuracy for detecting coronary artery disease (CAD) and a key role in the management of patients with low-to-intermediate pretest likelihood of CAD. However, the clinical information provided by this noninvasive method is still regarded insufficient in patients with diffuse and complex CAD and for planning percutaneous coronary intervention (PCI) and surgical revascularization procedures. On the other hand, technology advancements have recently shown to improve CCTA diagnostic accuracy in patients with diffuse and calcific stenoses. Moreover, stress CT myocardial perfusion imaging (CT-MPI) and fractional flow reserve derived from CCTA (CT-FFR) have been introduced in clinical practice as new tools for evaluating the functional relevance of coronary stenoses, with the possibility to overcome the main CCTA drawback, i.e. anatomical assessment only. The potential value of CCTA to plan and guide interventional procedures lies in the wide range of information it can provide: a) detailed evaluation of plaque extension, volume and composition; b) prediction of procedural success of CTO PCI using scores derived from CCTA; c) identification of coronary lesions requiring additional techniques (e.g., atherectomy and lithotripsy) to improve stent implantation success by assessing calcium score and calcific plaque distribution; d) assessment of CCTA-derived Syntax Score and Syntax Score II, which allows to select the mode of revascularization (PCI or CABG) in patients with complex and multivessel CAD. The aim of this Consensus Document is to review and discuss the available data supporting the role of CCTA, CT-FFR and stress CT-MPI in the preprocedural and possibly intraprocedural planning and guidance of myocardial revascularization interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
50. CAD-RADS™ 2.0 - 2022 Coronary Artery Disease-Reporting and Data System: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR),...
- Author
-
Cury, Ricardo C., Leipsic, Jonathon, Abbara, Suhny, Achenbach, Stephan, Berman, Daniel, Bittencourt, Marcio, Budoff, Matthew, Chinnaiyan, Kavitha, Choi, Andrew D., Ghoshhajra, Brian, Jacobs, Jill, Koweek, Lynne, Lesser, John, Maroules, Christopher, Rubin, Geoffrey D., Rybicki, Frank J., Shaw, Leslee J., Williams, Michelle C., Williamson, Eric, and White, Charles S.
- Abstract
Coronary Artery Disease Reporting and Data System (CAD-RADS) was created to standardize reporting system for patients undergoing coronary CT angiography (CCTA) and to guide possible next steps in patient management. The goal of this updated 2022 CAD-RADS 2.0 is to improve the initial reporting system for CCTA by considering new technical developments in Cardiac CT, including data from recent clinical trials and new clinical guidelines. The updated CAD-RADS classification will follow an established framework of stenosis, plaque burden, and modifiers, which will include assessment of lesion-specific ischemia using CT fractional-flow-reserve (CT-FFR) or myocardial CT perfusion (CTP), when performed. Similar to the method used in the original CAD-RADS version, the determinant for stenosis severity classification will be the most severe coronary artery luminal stenosis on a per-patient basis, ranging from CAD-RADS 0 (zero) for absence of any plaque or stenosis to CAD-RADS 5 indicating the presence of at least one totally occluded coronary artery. Given the increasing data supporting the prognostic relevance of coronary plaque burden, this document will provide various methods to estimate and report total plaque burden. The addition of P1 to P4 descriptors are used to denote increasing categories of plaque burden. The main goal of CAD-RADS, which should always be interpreted together with the impression found in the report, remains to facilitate communication of test results with referring physicians along with suggestions for subsequent patient management. In addition, CAD-RADS will continue to provide a framework of standardization that may benefit education, research, peer-review, artificial intelligence development, clinical trial design, population health and quality assurance with the ultimate goal of improving patient care. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.